StonvexLoading…
StonvexCore line items from DVA's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2020 2020-12-31 | Annual 2019 2019-12-31 | Annual 2018 2018-12-31 | Annual 2017 2017-12-31 |
|---|---|---|---|---|
Revenue | $11.04B | $10.92B | $10.71B | $10.09B |
Operating Income | $1.69B | $1.64B | $1.53B | $1.81B |
Net Income | $773.64M | $810.98M | $159.39M | $663.62M |
EPS (Diluted) | $6.31 | $5.27 | $0.92 | $3.47 |
Total Assets | $16.99B | $17.31B | $19.11B | $18.97B |
Total Liabilities | $14.09B | $13.81B | $14.08B | $13.08B |
Cash & Equivalents | $324.96M | $1.10B | $323.04M | $508.23M |
Free Cash Flow OCF − CapEx | $1.30B | $1.31B | $784.50M | $1.01B |
Shares Outstanding | 109.93M | 125.84M | 166.39M | 182.46M |